Personality Disorders and the 3-Year Course of Alcohol, Drug, and Nicotine Use Disorders

Department of Psychiatry, College of Physicians and Surgeons, Columbia University, NY 10032, USA.
Archives of general psychiatry (Impact Factor: 14.48). 11/2011; 68(11):1158-67. DOI: 10.1001/archgenpsychiatry.2011.136
Source: PubMed


Little is known about the role of a broad range of personality disorders in the course of substance use disorder (SUD) and whether these differ by substance. The existing literature focuses mostly on antisocial personality disorder and does not come to clear conclusions.
To determine the association between the 10 DSM-IV personality disorders and the persistence of common SUDs in a 3-year prospective study of a national sample.
Data were drawn from participants in the National Epidemiologic Survey on Alcohol and Related Conditions (NESARC) who had alcohol dependence (n = 1172), cannabis use disorder (n = 454), or nicotine dependence (n = 4017) at baseline and who were reinterviewed 3 years later. Control variables included demographic characteristics, family history of substance disorders, baseline Axis I disorders and treatment status, and prior SUD duration. Main Outcome Measure Persistent SUD, defined as meeting full criteria for the relevant SUD throughout the 3-year follow-up period.
Persistent SUD was found among 30.1% of participants with alcohol dependence, 30.8% with cannabis use disorder, and 56.6% with nicotine dependence at baseline. Axis I disorders did not have strong or consistent associations with persistent SUD. In contrast, antisocial personality disorder was significantly associated with persistent alcohol, cannabis, and nicotine use disorders (adjusted odds ratios, 2.46-3.51), as was borderline personality disorder (adjusted odds ratios, 2.04-2.78) and schizotypal personality disorder (adjusted odds ratios, 1.65-5.90). Narcissistic, schizoid, and obsessive-compulsive personality disorders were less consistently associated with SUD persistence.
The consistent findings on the association of antisocial, borderline, and schizotypal personality disorders with persistent SUD indicates the importance of these personality disorders in understanding the course of SUD. Future studies should examine dimensional representations of personality disorders and the role of specific components of these disorders, biological and environmental contributors to these relationships, and potential applications of these findings to treatment development.

Download full-text


Available from: Katherine M Keyes,
    • "It has also been shown that PD is associated with worse substance-related outcomes in SUD patients compared to SUD patients without PD (Van den Bosch & Verheul, 2007). Moreover, SUD is more persistent in patients with comorbid PD, especially antisocial, borderline, and schizotypal PD, while this was not found for Axis I disorders (Hasin et al., 2011). Thus, screening for PD among patients with SUD is important, because the presence of a PD informs the intensity and form of treatment that will be recommended (Zimmerman, Rothschild, & Chelminski, 2005). "

    European Journal of Psychological Assessment 09/2015; DOI:10.1027/1015-5759/a000282 · 2.53 Impact Factor
    • "Background Impulse-control disorders and antisocial personality disorders are very common in patients affected by substance dependence, particularly alcoholics (Hasin et al. 2011; Lewis 2011). In the context of alcohol consumption there are different categories of consumers . "
    [Show abstract] [Hide abstract]
    ABSTRACT: The hypothalamic pituitary adrenal axis and dopamine have a key role in transition from alcohol social use to addiction. The medial prefrontal cortex was shown to modulate dopaminergic activity and cortisol releasing factor (CRF) release in hypothalamic and extra-hypothalamic systems. The recent advancements in non-invasive neurostimulation technologies has enabled stimulation of deeper brain regions using H-coil transcranial magnetic stimulation (TMS) in humans. This randomized double-blind placebo-controlled pilot study aims to evaluate H-coil efficacy in stimulating the medial prefrontal cortex. Cortisolemia and prolactinemia were evaluated as effectiveness markers. Alcohol intake and craving were considered as secondary outcomes. Eighteen alcoholics were recruited and randomized into 2 homogeneous groups: 9 in the real stimulation group and 9 in the sham stimulation group. Repetitive TMS (rTMS) was administered through a magnetic stimulator over 10 sessions at 20 Hz, directed to the medial prefrontal cortex. rTMS significantly reduced blood cortisol levels and decreased prolactinemia, thus suggesting dopamine increase. Craving visual analogic scale (VAS) in treated patients decreased, as well as mean number of alcoholic drinks/day and drinks on days of maximum alcohol intake (DMAI). In the sham group there was no significant effect observed on cortisolemia, prolactinemia, mean number of alcoholic drinks/day, or drinks/DMAI. Thus, deep rTMS could be considered a potential new treatment for alcoholism.
    Canadian Journal of Physiology and Pharmacology 03/2015; 93(4):1-8. DOI:10.1139/cjpp-2014-0188 · 1.77 Impact Factor
    • "The co-occurrence of one or more personality disorders was found to be positive correlated with the severity of addiction (Preuss et al. 2009). In patients with alcohol dependence and cannabis use disorders, BPD, ASPD and schizotypal personality disorder were diagnosed most often (Hasin et al. 2011). "
    [Show abstract] [Hide abstract]
    ABSTRACT: Substance use disorders are highly prevalent among people with schizophrenia. Dually diagnosed patients present with unfavorable course and poor long-term outcomes. Integrated, motivation-based treatment for both disorders in the same setting is considered the treatment of choice for this challenging population. Treatment programs include state-of-the-art pharmacotherapy and psychosocial interventions such as motivational interviewing, psychoeducation, and cognitive–behavioral approaches.
    Co-occurring Addictive and Psychiatric Disorders, 01/2015: pages 75-86; , ISBN: 978-3-642-45374-8
Show more